These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28903331)

  • 1. The antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation status.
    Mohammed F; Stones DH; Zarling AL; Willcox CR; Shabanowitz J; Cummings KL; Hunt DF; Cobbold M; Engelhard VH; Willcox BE
    Oncotarget; 2017 Aug; 8(33):54160-54172. PubMed ID: 28903331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles.
    Molvi Z; Klatt MG; Dao T; Urraca J; Scheinberg DA; O'Reilly RJ
    J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37775115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self.
    Mohammed F; Cobbold M; Zarling AL; Salim M; Barrett-Wilt GA; Shabanowitz J; Hunt DF; Engelhard VH; Willcox BE
    Nat Immunol; 2008 Nov; 9(11):1236-43. PubMed ID: 18836451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles.
    Molvi Z; Klatt MG; Dao T; Urraca J; Scheinberg DA; O'Reilly RJ
    bioRxiv; 2023 Feb; ():. PubMed ID: 36798179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL.
    Andersen MH; Bonfill JE; Neisig A; Arsequell G; Sondergaard I; Valencia G; Neefjes J; Zeuthen J; Elliott T; Haurum JS
    J Immunol; 1999 Oct; 163(7):3812-8. PubMed ID: 10490979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intercellular and intracellular events following the MHC-unrestricted TCR recognition of a tumor-specific peptide epitope on the epithelial antigen MUC1.
    Magarian-Blander J; Ciborowski P; Hsia S; Watkins SC; Finn OJ
    J Immunol; 1998 Apr; 160(7):3111-20. PubMed ID: 9531265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous presentation of a nascent antigenic epitope to CD8+ CTL is more efficient than exogenous presentation.
    Hahn YS; Hahn CS; Braciale TJ
    Immunol Cell Biol; 1996 Oct; 74(5):394-400. PubMed ID: 8912001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of peptide binding patterns in different major histocompatibility complex/T cell receptor complexes using pigeon cytochrome c-specific T cell hybridomas. Evidence that a single peptide binds major histocompatibility complex in different conformations.
    Bhayani H; Paterson Y
    J Exp Med; 1989 Nov; 170(5):1609-25. PubMed ID: 2553848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural analysis of two HLA-DR-presented autoantigenic epitopes: crucial role of peripheral but not central peptide residues for T-cell receptor recognition.
    De Oliveira DB; Harfouch-Hammoud E; Otto H; Papandreou NA; Stern LJ; Cohen H; Boehm BO; Bach J; Caillat-Zucman S; Walk T; Jung G; Eliopoulos E; Papadopoulos GK; van Endert PM
    Mol Immunol; 2000 Oct; 37(14):813-25. PubMed ID: 11257303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.
    Leclerc M; Mezquita L; Guillebot De Nerville G; Tihy I; Malenica I; Chouaib S; Mami-Chouaib F
    Front Immunol; 2019; 10():1505. PubMed ID: 31333652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A TCR mimic monoclonal antibody reactive with the "public" phospho-neoantigen pIRS2/HLA-A*02:01 complex.
    Dao T; Mun SS; Molvi Z; Korontsvit T; Klatt MG; Khan AG; Nyakatura EK; Pohl MA; White TE; Balderes PJ; Lorenz IC; O'Reilly RJ; Scheinberg DA
    JCI Insight; 2022 Mar; 7(5):. PubMed ID: 35260532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-canonical anchor motif peptides bound to MHC class I induce cellular responses.
    Lazoura E; Lodding J; Farrugia W; Day S; Ramsland PA; Apostolopoulos V
    Mol Immunol; 2009 Mar; 46(6):1171-8. PubMed ID: 19118903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy.
    Zarling AL; Polefrone JM; Evans AM; Mikesh LM; Shabanowitz J; Lewis ST; Engelhard VH; Hunt DF
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14889-94. PubMed ID: 17001009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage.
    Carson RT; Vignali KM; Woodland DL; Vignali DA
    Immunity; 1997 Sep; 7(3):387-99. PubMed ID: 9324359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-canonical peptides bound to MHC.
    Day SL; Ramsland PA; Apostolopoulos V
    Curr Pharm Des; 2009; 15(28):3274-82. PubMed ID: 19860676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen.
    Ehrich EW; Devaux B; Rock EP; Jorgensen JL; Davis MM; Chien YH
    J Exp Med; 1993 Aug; 178(2):713-22. PubMed ID: 8393480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of a tumor-derived peptide at an HLA-A2 anchor residue can alter the conformation of the MHC-peptide complex: probing with TCR-like recombinant antibodies.
    Denkberg G; Klechevsky E; Reiter Y
    J Immunol; 2002 Oct; 169(8):4399-407. PubMed ID: 12370373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the molecular nature of "restrictive" antigenic elements present on major histocompatibility complex (MHC) proteins.
    Novotny J; Bruccoleri RE; Kourilsky P
    Res Immunol; 1989 Feb; 140(2):145-58. PubMed ID: 2472656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunobiological analysis of TCR single-chain transgenic mice reveals new possibilities for interaction between CDR3alpha and an antigenic peptide bound to MHC class I.
    Zhang W; Honda S; Wang F; DiLorenzo TP; Kalergis AM; Ostrov DA; Nathenson SG
    J Immunol; 2001 Oct; 167(8):4396-404. PubMed ID: 11591764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.